Renerve Plus Capsule comes in a pack of 15 soft gelatin capsules and is manufactured by Strides Arcolab Ltd., one of the leading pharmaceutical companies in India. The drug has been approved by the Central Drugs Standard Control Organization (CDSCO) and is now available in pharmacies across the country.
Neuropathy is a condition that affects the nerves in the body, causing pain, numbness, tingling, and weakness in the affected area. It can be caused by various factors, including diabetes, chemotherapy, and trauma. Renerve Plus Capsule helps in the management of neuropathy symptoms by providing the essential nutrients required by the body to maintain nerve health.
Folic Acid, which is present in Renerve Plus Capsule, is a B-vitamin that is necessary for the formation of red blood cells and DNA. It also helps in the maintenance of nerve health and has been found to be effective in reducing the symptoms of neuropathy. The other active ingredients in the drug, such as Methylcobalamin, Alpha Lipoic Acid, and Vitamin B6, are also essential for nerve health and function.
TECSUN PHARMA LIMITED has a strong presence in the Indian market, with a wide range of pharmaceutical products for human and veterinary use. The company has been actively involved in research and development, bringing innovative products to the market that meet the needs of patients and healthcare professionals.
Commenting on the launch of Renerve Plus Capsule, a spokesperson for TECSUN PHARMA LIMITED said, "We are delighted to introduce Renerve Plus Capsule to the Indian market. Neuropathy is a common condition that affects many people, and we believe that our product will make a significant difference in the lives of those suffering from this condition. At TECSUN PHARMA LIMITED, we are committed to bringing high-quality, affordable pharmaceutical products to the market, and Renerve Plus Capsule is a testament to our commitment."
The company has also launched a comprehensive marketing campaign to promote the drug, including digital and print advertisements, medical conferences, and other promotional activities. The campaign aims to raise awareness about neuropathy and the benefits of Renerve Plus Capsule in managing its symptoms.
In conclusion, with the launch of Renerve Plus Capsule, TECSUN PHARMA LIMITED continues to strengthen its position in the Indian pharmaceutical market. The drug offers a safe and effective treatment option for neuropathy and related conditions, providing much-needed relief to patients. As the company continues to grow and expand its product portfolio, it remains committed to its mission of improving the health and wellbeing of people across the country.